Featured News

Our Partners

Latest News

CellectGen Advances Periodontal Diagnostics in Collaboration with Kemp Proteins and DCNDx

Pasadena, CA,— CellectGen has received Small Business Innovation Research (SBIR) funding to develop a saliva-based, point-of-care diagnostic platform for periodontal disease, focused on early detection of active tissue destruction. About 42% of U.S. adults over 30 have periodontal disease, a leading cause of adult tooth loss that contributes to an estimated $154 billion in direct […]

Maryland, Virginia Life Sciences News: QIAGEN $12.1 Billion Takeover, LUNGevity Launches Multi-Year Research & More 

BioHealth Capital Region – Regional Life Sciences Roundup – October 30, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a […]

People on the Move: Sean Stowe Returns to FUJIFILM Biotechnologies as Associate Director, Program Design, Biologics

A Research Triangle-based biologics and CDMO leader rejoins FUJIFILM to help clients turn biologic therapies into development and manufacturing programs. Sean Stowe, Ph.D., has joined FUJIFILM Biotechnologies as Associate Director, Program Design, Biologics, starting in October 2026. Based in the Raleigh-Durham-Chapel Hill area, Stowe returns to the company, then known as FUJIFILM Diosynth Biotechnologies, where […]

People on the Move: Opus Genetics Names Andrew Murphy Chief Scientific Officer and Jamie Lynne Hart Executive Director, Executive Operations

RTP gene therapy company strengthens its scientific and operational leadership as it advances treatments for inherited retinal diseases. Opus Genetics (Nasdaq: IRD), a Research Triangle Park, North Carolina-based clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases, announced on October 29, 2026 the appointments of Andrew Murphy, Ph.D., as Chief Scientific Officer and Jamie […]